EOM Pharmaceutical Holdings Inc. (IMUC)

[buccaneer1961]

ImmunoCellular shares are down over 60% in early morning trading on the announcement, trading as low as $.98 per share. However, certain officers and directors, including the founder and Chairman, sold their personally held shares at prices as high as $3.86 per shares before this news was released.

Johnson & Weaver’s investigation will seek to determine if investors were previously misled by ImmunoCellular’s officers or directors concerning ICT-107’s potential.